Oncology Pharmacy Residency
The Children’s National Postgraduate Year Two (PGY-2) Oncology Pharmacy Residency Program is a Pediatric Oncology pharmacy-focused program that provides learning experiences centered on patient care and practice management that will enable residency graduates to pursue advanced clinical pharmacist and clinical specialist positions in oncology after completion of the program.
The residency program will also provide teaching opportunities that will develop pedagogical skills in the context of adjunct faculty appointments with affiliated pharmacy schools. An optional teaching certificate program will be available through the University of Maryland (this will be required for residents who have not previously completed one). The Division of Pharmacy is affiliated with Howard University School of Pharmacy, University of Maryland School of Pharmacy, Virginia Commonwealth University and Shenandoah University as well as other pharmacy schools around the country.
Prerequisites:
Potential candidates for Children’s National Health System Pharmacy Postgraduate Year Two (PGY2) Residency Program should submit an application in accordance with the date listed in PhORCAS.
How To apply:
The residency year begins on July 1st. The items below should be submitted with your application through PHORCAS:
- Current Curriculum Vitae
- It should include (but not be limited to) schools or universities attended (including dates), degrees conferred or expected, honors and awards, extracurricular activities, work experience, clinical rotations (completed and scheduled) and other pertinent information.
- Three letters of recommendation
- Two of which are from clinical or academic faculty/preceptor and one from the most recent employer (PGY1 RPD counts)
- Each individual who is writing a recommendation will submit directly to PhORCAS. Each reference writer must provide comments in at least three fields, in particular:
- Independence and resourcefulness
- Ability to work with peers and communicate effectively
- Emotional stability and maturity
Contact Information:
Radha Rohatgi, PharmD, BCOP
BMT Clinical Pharmacy Specialist
PGY-2 Oncology Residency Program Director
Children’s National Hospital
Division of Pharmacy, M4847
111 Michigan Avenue NW
Washington, DC 20010-2916
